PANDA 2

Pathology: Age-Related Macular Degeneration (AMD)

Description: Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular Age-related Macular Degeneration

Study Objectives: The purpose of this clinical study is to evaluate the efficacy and safety of two different levels of conbercept intravitreal (IVT) injection as compared to the approved vascular endothelial growth factor (VEGF) antagonist active control, aflibercept intravitreal injection (2.0 mg/eye, Eylea®), in subjects with neovascular AMD.

Principal Investigator: Dr. Dang

Status: Open Enrollment


MATRIX

Pathology: Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR) and Macular Edema (ME)

Description: We will performing fundoscopic exams to check for NPDR, PDR and ME

Principal Investigator: In connection with Dr. Timothy Smith’s office

Status: Open Enrollment